Valuation: DexCom, Inc.

Market Cap 2.76TCr 2.43TCr 2.26TCr 2.07TCr 3.9TCr 2,64700Cr 3.95TCr 27TCr 10TCr 1,30700Cr 10TCr 10TCr 4,51800Cr P/E 2026 *
29.1x
P/E 2027 * 24.3x
Enterprise Value 2.72TCr 2.39TCr 2.22TCr 2.04TCr 3.84TCr 2,60600Cr 3.89TCr 26TCr 10TCr 1,28700Cr 10TCr 9.98TCr 4,44800Cr EV / Sales 2026 *
5.2x
EV / Sales 2027 * 4.52x
Free-Float
93.35%
Yield 2026 *
-
Yield 2027 * -
1 day+3.04%
1 week-6.29%
Current month-0.32%
1 month-0.32%
3 months+15.93%
6 months+1.72%
Current year+9.14%
1 week 62
Extreme 62
65.8
1 month 62
Extreme 62
68.6
Current year 48.8
Extreme 48.8
68.6
1 year 47
Extreme 47
77.99
3 years 47
Extreme 47
131.78
5 years 47
Extreme 47
145.65
10 years 47
Extreme 47
145.65
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+0.97%-6.29% - - 2.76TCr
+1.39%+3.78%-17.43%-8.41% 18TCr
+1.21%+1.23%-9.38%-6.84% 11TCr
+0.41%+1.06%+7.16%+65.76% 6.03TCr
+0.67%-1.94%+27.88%+55.85% 5.02TCr
+1.64%+0.47%-14.25%-43.80% 4.31TCr
+2.45%-0.23% - - 3.28TCr
+0.93%-7.53%+25.71%-12.70% 2.31TCr
+2.02%+0.26%-5.23%-5.81% 2.09TCr
+3.90%-0.82%-13.10%+1.56% 1.95TCr
Average +1.91%-2.00%+0.17%+5.70% 5.95TCr
Weighted average by Cap. +1.73%-0.22%-5.33%+4.49%

Financials

2026 *2027 *
Net sales 522.4Cr 459.25Cr 427.5Cr 392.6Cr 737.22Cr 50TCr 746.93Cr 5.08TCr 1.98TCr 25TCr 1.96TCr 1.92TCr 86TCr 582.66Cr 512.22Cr 476.81Cr 437.89Cr 822.26Cr 56TCr 833.09Cr 5.67TCr 2.21TCr 28TCr 2.19TCr 2.14TCr 95TCr
Net income 96Cr 84Cr 79Cr 72Cr 135.4Cr 9.2TCr 137.18Cr 933.28Cr 364.5Cr 4.54TCr 360.17Cr 352.41Cr 16TCr 115.73Cr 101.74Cr 95Cr 87Cr 163.32Cr 11TCr 165.48Cr 1.13TCr 439.67Cr 5.48TCr 434.45Cr 425.09Cr 19TCr
Net Debt -43Cr -38Cr -35Cr -32Cr -60Cr -4.11TCr -61Cr -417.01Cr -162.87Cr -2.03TCr -160.93Cr -157.47Cr -7.02TCr -128.06Cr -112.58Cr -104.8Cr -96Cr -180.72Cr -12TCr -183.1Cr -1.25TCr -486.5Cr -6.06TCr -480.72Cr -470.36Cr -21TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
24/26/24 €62.60 +0.97% 0
23/26/23 €62.00 -2.82% 10
22/26/22 €63.80 -3.04% 0
21/26/21 €65.80 -2.08% 0
20/26/20 €67.20 +0.60% 60
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
71.54USD
Average target price
86.12USD
Spread / Average Target
+20.38%

Quarterly revenue - Rate of surprise